Member Spotlight: Mohammed Al-Sofiani, MD, MSc

MemberSpotlightAug2022

Mohammed Al-Sofiani, MD, MSc, is an assistant professor of endocrinology, diabetes, and metabolism at King Saud University (KSU), Riyadh, Saudi Arabia, and is an adjunct assistant professor at Johns Hopkins University in Baltimore, Md.

He serves as the vice president of the Saudi Society of Endocrinology and Metabolism and the chief scientific officer (CSO) of the first specialized diabetes echosystem and artificial intelligence platform in the Middle East (KARAZ). He is also the director of the Endocrinology, Diabetes, and Metabolism Fellowship Training Program at KSU.

Al-Sofiani’s research focuses on the digital transformation of diabetes care in the Middle East to improve the quality, efficiency, and safety of diabetes care and overcome barriers to access to care in various parts of the Middle East. He has authored many scientific papers and book chapters and has given over 200 oral presentations in regional and international conferences and is the recipient of the 2019 Endocrine Society Clinical Fellow Award in Diabetes among several other prestigious awards.

What is your favorite Endocrine Society memory?

Over the years, the ENDO meetings have provided me with the opportunity to network with peers and giants in endocrinology from all over the world; many of whom have since become colleagues, friends, and mentors. My favorite Endocrine Society memory is when our abstract was selected for oral presentation and awarded the Endocrine Society Clinical Fellow Award in Diabetes in 2019.

I have always been amazed by how the various hormones coordinate our body’s functions from metabolism to growth, development, sleep, emotions, mood, sexual activities, and many other vital functions.

How has Endocrine Society supported your professional development/career journey?

Through the Endocrine Society, I got the chance to give my first oral presentations at a national/international level. I still remember the day when I gave one of those talks as a resident and was approached shortly after by the program director of one of the prestigious endocrinology fellowship programs in the U.S., who complimented my presentation and was kind enough to offer me an invitation for a fellowship interview should I be interested.

The Early Career Forum is another Endocrine Society program that helped me become a better endocrine fellow during my training years and a productive junior faculty later on through boosting my knowledge, skills, confidence, and by expanding my network early on in my development and career journey.

What experience led you to the study of the endocrine system?

I have always been amazed by how the various hormones coordinate our body’s functions from metabolism to growth, development, sleep, emotions, mood, sexual activities, and many other vital functions. This along with the fact that I come from a community where diabetes is extremely prevalent have shaped my interest in endocrinology, diabetes, and metabolism. My home country, Saudi Arabia, is among the top 10 countries in diabetes prevalence worldwide, and I have seen firsthand how the lack of appropriate management of diabetes can negatively impact the health, quality of life, and productivity of people with diabetes.  

Read more about your fellow Endocrine Society members at: www.endocrine.org/member-spotlight.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in